RecruitingNot Applicable

Patient-Centered Practical Vaccine Talk For Busy Clinicians

United States24,500 participantsStarted 2026-07-15

Plain-language summary

The goal of this study is to assess the effect of an educational intervention for primary care providers (PCPs) on influenza and COVID-19 vaccine uptake among their adult patients through a pragmatic, cluster randomized trial in primary care clinics.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria for primary care provider participants are as follows: * Practicing primary care provider at study clinic during the study period * Licensed independent practitioner (MD, DO, NP, PA), including residents Exclusion criteria for primary care provider participants are as follows: * PCPs at participating clinic sites who are members of the investigational team or part of the intervention * PCP participants who practice at more than one study clinic that are assigned to discordant study arms (e.g., control and intervention) will be excluded at the outset of the study. Inclusion criteria for patient participants are specified for each of the two co-primary outcomes as follows: Receipt of the 2026/2027 influenza vaccine, among eligible patients: * Have a qualifying clinic visit, defined as a clinic visit with a study PCP at one of the study clinics during the 2026/2027 influenza vaccine season\* * Have not received the 2026-2027 influenza vaccine prior to the qualifying clinic visit (patients who receive the influenza vaccine on the day of the qualifying study visit are eligible) * Adult (age \>= 18 years) Receipt of the 2026/2027 COVID-19 vaccine, among eligible patients: * Have a qualifying clinic visit, defined as a clinic visit with a study PCP at one of the study clinics during the 2026/2027 COVID-19 vaccine season\* * Have not received the 2026-2027 COVID-19 vaccine prior to the qualifying study visit (patients who receive the COVID-19 vaccine on the…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1This trial seems to be about how doctors talk to patients about flu and COVID-19 vaccines — does participating mean I'd be receiving a specific vaccine communication approach from my care team, and how would that actually affect my appointments?
2Since the study is tracking whether I get the 2026/2027 flu and COVID-19 vaccines, would enrolling create any obligation or expectation around which vaccines I receive, or is it purely observational on my end?
3Given that this trial has no listed phase, which suggests it may be focused on care delivery or communication rather than testing a new treatment, can you help me understand what the actual risk or burden of participating would be for me?
4Would taking part in this study change anything about the standard vaccine recommendations you'd already be giving me, or would I receive the same guidance I'd normally get as your patient?
5If I'm already planning to get my flu and COVID-19 vaccines this season, is there any meaningful reason to discuss enrollment in this trial, or would my participation mainly help researchers improve how doctors communicate vaccine information to patients like me?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Receipt of 2026/2027 influenza vaccine

Timeframe: Within one month of the end of the study period

Receipt of 2026/2027 COVID-19 vaccine

Timeframe: Within one month of the end of the study period

Trial details

NCT IDNCT07651761

SponsorUniversity of Massachusetts, Worcester

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-05-15

Contact for this trial

Kimberly A Fisher, MD

(508) 334-1975 kimberly.fisher2@umassmed.edu

View on ClinicalTrials.gov More Influenza trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.